Understand the complete disease landscape and size global markets with real-world data. DRG’s Epidemiology cover 140+ diseases, 40+ countries, 3,400 patient segments, including extensive insights of oncology populations by stage, line of therapy, and biomarker. Learn more about DRG Epidemiology here.

The poster below was presented by DRG Epidemiologist Narendra Parihar, BDS, MPH at European Society for Medical Oncology on The Global Forecast of Prostate Cancer Drug-Treatable Populations Eligible for Targeted Anticancer Therapies (2017-2027).




How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now